PRESS RELEASE published on 03/31/2023 at 08:50, 2 years 10 months ago Sartorius Stedim Biotech SA: Sartorius Stedim Biotech to acquire Polyplus
PRESS RELEASE published on 03/27/2023 at 18:30, 2 years 10 months ago Sartorius Stedim Biotech SA: René Fáber takes over as Chief Executive Officer of Sartorius Stedim Biotech S.A.; Joachim Kreuzburg remains Chairman of the Board
PRESS RELEASE published on 03/07/2023 at 10:55, 2 years 11 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
PRESS RELEASE published on 02/17/2023 at 08:41, 3 years ago Sartorius Stedim Biotech SA: Information on Document Availability
PRESS RELEASE published on 02/08/2023 at 16:15, 3 years ago Sartorius Stedim Biotech SA: Board of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 1.44 euros per share to the Annual Shareholders’ Meeting
PRESS RELEASE published on 02/06/2023 at 14:55, 3 years ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
PRESS RELEASE published on 01/05/2023 at 11:18, 3 years 1 month ago Half-year liquidity contract statement for Sartorius Stedim Biotech
PRESS RELEASE published on 01/03/2023 at 11:03, 3 years 1 month ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Published on 02/21/2026 at 00:45, 22 hours 34 minutes ago Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 22 hours 49 minutes ago Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:00, 1 day ago Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/20/2026 at 22:17, 1 day 1 hour ago Organto Foods Completes Warrant Exercise Incentive Program
Published on 02/21/2026 at 12:00, 11 hours 19 minutes ago Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Published on 02/20/2026 at 18:36, 1 day 4 hours ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 1 day 4 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:00, 1 day 5 hours ago Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations
Published on 02/20/2026 at 09:28, 1 day 13 hours ago Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026
Published on 02/20/2026 at 07:30, 1 day 15 hours ago Announcement of share buyback in the context of a share purchase plan
Published on 02/20/2026 at 07:30, 1 day 15 hours ago EURAZEO COMPLETES THE SALE OF EX NIHILO TO L CATTERTON
